Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Developing a disposable drug delivery system which initially will be used for insulin delivery for Type I diabetics.Funding
Funding rounds
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Thomas McNerney & Partners LLC | Healthcare venture firm. | United States |
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
De Novo Ventures |
+1 (650) 329-1999 |
N/A | |
Novo A/S |
N/A | ||
Seed Capital |
N/A | ||
Sunstone Life Science Ventures |
N/A | ||
Thomas McNerney & Partners LLC Healthcare venture firm. |
+1 (203) 978-2000 |
N/A |